Closing the Gap: Increasing Global Competition to Attract and Grow the Biopharmaceutical Sector

The biopharmaceutical industry stands out as a leading U.S. industry in which the United States has earned a position of global leadership through innovation. In turn, this global leadership is generating substantial economic benefits and health dividends for the United States. The biopharmaceutical industry’s economic benefit in the United States is amplified by its large-scale supply chain for research and development (R&D), manufacturing, and distribution activities.